ZLD
Click for more information
2.44% 84.0¢ zelira therapeutics limited

Ann: Zelda to merge with US-based Ilera Therapeutics, page-83

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. FiSaver
    2,120 Posts.
    lightbulb Created with Sketch. 577
    clock Created with Sketch.
    11/10/19
    05:32
    Post #: 40826378
    I too woke up early (2.30am here in nz) the call was good and I came away positive. for me once again the key direction from the Ilera merger is to gain early benefit realisation from the clinical data assets Zelda has though the USA and ex US. aka revenue generating.

    the company needs to think further ahead that just near term trial results. but what to do with them ilera make that path clear.

    I was very happy on the talk of IP and USA markets
    ZLD Price at posting: 7.6¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Oversubscribed share purchase plan successfully raises $2.3 million, with all applications accepted in full
right-arrow Created with Sketch.
BM8 Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS Scoping study unveils promising economics for the Ngami Copper Project, with potential copper resources up to 166Mt — find out more about what makes this a game-changer
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
84.0¢ 		Change
0.020(2.44%) 		Mkt cap ! $9.531M
Open High Low Value Volume
82.0¢ 84.0¢ 82.0¢ $110 131

Buyers (Bids)

No. Vol. Price($)
1 10 85.5¢
 

Sellers (Offers)

Price($) Vol. No.
89.5¢ 1500 1
View Market Depth
Last trade - 14.12pm 18/10/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.